Insulin signalling to the kidney in health and disease

Clinical Science

Volumn 124, Issue 6, 2013, Pages 351-370

  Hale, Lorna J ^a   Coward, Richard J M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Diabetes; Diabetic nephropathy; Insulin; Intracellular signalling; Kidney; Metabolic syndrome

Indexed keywords

CALCIUM ION; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; RAPAMYCIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

CELL FUNCTION; DIABETES MELLITUS; GLOMERULUS; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; KIDNEY; KIDNEY BLOOD FLOW; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MESANGIUM CELL; METABOLIC SYNDROME X; NEPHRON; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; REVIEW;

GLUCONEOGENESIS; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY; KIDNEY GLOMERULUS; METABOLIC SYNDROME X; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; RENAL CIRCULATION; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84872256154     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120378     Document Type: Review

References (210)

1. Banting, F. G., Best, C. H., Collip, J. B., Campbell, W. R. and Fletcher, A. A. (1922) Pancreatic extracts in the treatment of diabetes mellitus. Can. Med. Assoc. J. 12, 141-146
2. White, M. F. (2003) Insulin signaling in health and disease. Science 302, 1710-1711
3. White, M. F. and Kahn, C. R. (1994) The insulin signaling system. J. Biol. Chem. 269, 1-4
4. Megyesi, K., Kahn, C. R., Roth, J., Neville, Jr, D. M., Nissley, S. P., Humbel, R. E. and Froesch, E. R. (1975) The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor. J. Biol. Chem. 250, 8990-8996
5. Kim, J. J. and Accili, D. (2002) Signalling through IGF-I and insulin receptors: where is the specificity? Growth Horm. IGF Res. 12, 84-90
6. De Meyts, P. (2004) Insulin and its receptor: structure, function and evolution. BioEssays 26, 1351-1362
7. Belfiore, A., Frasca, F., Pandini, G., Sciacca, L. and Vigneri, R. (2009) Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr. Rev. 30, 586-623
8. Lee, J. and Pilch, P. F. (1994) The insulin receptor: structure, function and signaling. Am. J. Physiol. 266, C319-C334
9. Kasuga, M., Zick, Y., Blithe, D. L., Crettaz, M. and Kahn, C. R. (1982) Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298, 667-669
10. Ebina, Y., Ellis, L., Jarnagin, K., Edery, M., Graf, L., Clauser, E., Ou, J. H., Masiarz, F., Kan, Y. W., Goldfine, I. D. et al. (1985) The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40, 747-758
11. Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y. C., Tsubokawa, M. et al. (1985) Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313, 756-761
12. Bailyes, E. M., Nave, B. T., Soos, M. A., Orr, S. R., Hayward, A. C. and Siddle, K. (1997) Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem. J. 327, 209-215
13. Moller, D. E., Yokota, A., Caro, J. F. and Flier, J. S. (1989) Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol. Endocrinol. 3, 1263-1269
14. Samani, A. A., Yakar, S., LeRoith, D. and Brodt, P. (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr. Rev. 28, 20-47
15. Ullrich, A., Gray, A., Tam, A. W., Yang-Feng, T., Tsubokawa, M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., Chen, E. et al. (1986) Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5, 2503-2512
16. Kahn, B. B. (1992) Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J. Clin. Invest. 89, 1367-1374
17. Gannon, M. C., Nuttall, J. A. and Nuttall, F. Q. (2002) Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal. Am. J. Clin. Nutr. 76, 1016-1022
18. Pessin, J. E., Thurmond, D. C., Elmendorf, J. S., Coker, K. J. and Okada, S. (1999) Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location! J. Biol. Chem. 274, 2593-2596
19. Clarke, J. F., Young, P. W., Yonezawa, K., Kasuga, M. and Holman, G. D. (1994) Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem. J. 300, 631-635
20. Olson, A. L. and Pessin, J. E. (1996) Structure, function and regulation of the mammalian facilitative glucose transporter gene family. Annu. Rev. Nutr. 16, 235-256
21. Saltiel, A. R. and Kahn, C. R. (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806
22. Chang, L., Chiang, S. H. and Saltiel, A. R. (2004) Insulin signaling and the regulation of glucose transport. Mol. Med. 10, 65-71
23. Watson, R. T., Kanzaki, M. and Pessin, J. E. (2004) Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr. Rev. 25, 177-204
24. White, M. F. (2002) IRS proteins and the common path to diabetes. Am. J. Physiol. Endocrinol. Metab. 283, E413-E422
25. Cantley, L. C. (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655-1657
26. Wang, Q., Somwar, R., Bilan, P. J., Liu, Z., Jin, J., Woodgett, J. R. and Klip, A. (1999) Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol. Cell. Biol. 19, 4008-4018
27. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O. and Ui, M. (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269, 3568-3573
28. Isakoff, S. J., Taha, C., Rose, E., Marcusohn, J., Klip, A. and Skolnik, E. Y. (1995) The inability of phosphatidylinositol 3-kinase activation to stimulate GLUT4 translocation indicates additional signaling pathways are required for insulin-stimulated glucose uptake. Proc. Natl. Acad. Sci. U.S.A. 92, 10247-10251
29. Kohn, A. D., Summers, S. A., Birnbaum, M. J. and Roth, R. A. (1996) Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271, 31372-31378
30. Cong, L. N., Chen, H., Li, Y., Zhou, L., McGibbon, M. A., Taylor, S. I. and Quon, M. J. (1997) Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol. Endocrinol. 11, 1881-1890
31. Saltiel, A. R. and Pessin, J. E. (2002) Insulin signaling pathways in time and space. Trends Cell Biol. 12, 65-71
32. Baumann, C. A., Ribon, V., Kanzaki, M., Thurmond, D. C., Mora, S., Shigematsu, S., Bickel, P. E., Pessin, J. E. and Saltiel, A. R. (2000) CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407, 202-207
33. Chiang, S. H., Baumann, C. A., Kanzaki, M., Thurmond, D. C., Watson, R. T., Neudauer, C. L., Macara, I. G., Pessin, J. E. and Saltiel, A. R. (2001) Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410, 944-948
34. Mitra, P., Zheng, X. and Czech, M. P. (2004) RNAi-based analysis of CAP, Cbl and CrkII function in the regulation of GLUT4 by insulin. J. Biol. Chem. 279, 37431-37435
35. Dhillon, A. S., Hagan, S., Rath, O. and Kolch, W. (2007) MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290
36. McCubrey, J. A., Lahair, M. M. and Franklin, R. A. (2006) Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signaling 8, 1775-1789
37. Torii, S., Yamamoto, T., Tsuchiya, Y. and Nishida, E. (2006) ERK MAP kinase in G cell cycle progression and cancer. Cancer Sci. 97, 697-702
38. Schaeffer, H. J. and Weber, M. J. (1999) Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435-2444
39. Taniguchi, C. M., Emanuelli, B. and Kahn, C. R. (2006) Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7, 85-96
40. Rocchi, S., Tartare-Deckert, S., Murdaca, J., Holgado-Madruga, M., Wong, A. J. and Van Obberghen, E. (1998) Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules. Mol. Endocrinol. 12, 914-923
41. Cunnick, J. M., Mei, L., Doupnik, C. A. and Wu, J. (2001) Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2. J. Biol. Chem. 276, 24380-24387
42. Salcini, A. E., McGlade, J., Pelicci, G., Nicoletti, I., Pawson, T. and Pelicci, P. G. (1994) Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9, 2827-2836
43. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D. and Downward, J. (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532
44. Denton, R. M. and Tavare, J. M. (1995) Does mitogen-activatedprotein kinase have a role in insulin action? The cases for and against. Eur. J. Biochem. 227, 597-611
45. Bruning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Muller-Wieland, D. and Kahn, C. R. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science 289, 2122-2125
46. Baskin, D. G., Figlewicz Lattemann, D., Seeley, R. J., Woods, S. C., Porte, Jr, D. and Schwartz, M. W. (1999) Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res. 848, 114-123
47. Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C. and Porte, Jr, D. (1992) Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 13, 387-414
48. Schwartz, M. W., Sipols, A. J., Marks, J. L., Sanacora, G., White, J. D., Scheurink, A., Kahn, S. E., Baskin, D. G., Woods, S. C., Figlewicz, D. P. et al. (1992) Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130, 3608-3616
49. Bertrand, L., Horman, S., Beauloye, C. and Vanoverschelde, J. L. (2008) Insulin signalling in the heart. Cardiovasc. Res. 79, 238-248
50. Cabou, C., Cani, P. D., Campistron, G., Knauf, C., Mathieu, C., Sartori, C., Amar, J., Scherrer, U. and Burcelin, R. (2007) Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes. Diabetes 56, 2872-2877
51. Zeng, G. and Quon, M. J. (1996) Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98, 894-898
52. Coward, R. J., Welsh, G. I., Yang, J., Tasman, C., Lennon, R., Koziell, A., Satchell, S., Holman, G. D., Kerjaschki, D., Tavare, J. M. et al. (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54, 3095-3102
53. Arnqvist, H. J., Ballermann, B. J. and King, G. L. (1988) Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells. Am. J. Physiol. 254, C411-C416
54. Conti, F. G., Striker, L. J., Lesniak, M. A., MacKay, K., Roth, J. and Striker, G. E. (1988) Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology 122, 2788-2795
55. Elliot, S. J., Conti, F. G., Striker, L. J. and Striker, G. E. (1990) Mouse glomerular endothelial cells have an insulin receptor. Horm. Metab. Res. 22, 557-560
56. Butlen, D., Vadrot, S., Roseau, S. and Morel, F. (1988) Insulin receptors along the rat nephron: [125I] insulin binding in microdissected glomeruli and tubules. Pflugers Arch. 412, 604-612
57. Sechi, L. A., De Carli, S. and Bartoli, E. (1994) In situ characterization of renal insulin receptors in the rat. J. Recept. Res. 14, 347-356
58. Bourdeau, J. E., Chen, E. R. and Carone, F. A. (1973) Insulin uptake in the renal proximal tubule. Am. J. Physiol. 225, 1399-1404
59. Nakamura, R., Emmanouel, D. S. and Katz, A. I. (1983) Insulin binding sites in various segments of the rabbit nephron. J. Clin. Invest. 72, 388-392
60. Vienberg, S. G., Bouman, S. D., Sorensen, H., Stidsen, C. E., Kjeldsen, T., Glendorf, T., Sorensen, A. R., Olsen, G. S. andersen, B. and Nishimura, E. (2011) Receptor-isoform-selective insulin analogues give tissue-preferential effects. Biochem. J. 440, 301-308
61. Battezzati, A., Caumo, A., Martino, F., Sereni, L. P., Coppa, J., Romito, R., Ammatuna, M., Regalia, E., Matthews, D. E., Mazzaferro, V. et al. (2004) Nonhepatic glucose production in humans. Am. J. Physiol. Endocrinol. Metab. 286, E129-E135
62. Gerich, J. E., Meyer, C., Woerle, H. J. and Stumvoll, M. (2001) Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24, 382-391
63. Meyer, C., Dostou, J. M., Welle, S. L. and Gerich, J. E. (2002) Role of human liver, kidney and skeletal muscle in postprandial glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 282, E419-E427
64. Cersosimo, E., Garlick, P. and Ferretti, J. (1999) Insulin regulation of renal glucose metabolism in humans. Am. J. Physiol. 276, E78-E84
65. Meyer, C., Dostou, J., Nadkarni, V. and Gerich, J. (1998) Effects of physiological hyperinsulinemia on systemic, renal and hepatic substrate metabolism. Am. J. Physiol. 275, F915-F921
66. Burchell, A. and Hume, R. (1995) The glucose-6-phosphatase system in human development. Histol. Histopathol. 10, 979-993
67. Martens, D. H., Rake, J. P., Navis, G., Fidler, V., van Dael, C. M. and Smit, G. P. (2009) Renal function in glycogen storage disease type I, natural course and renopreservative effects of ACE inhibition. Clin. J. Am. Soc. Nephrol. 4, 1741-1746
68. Liang, C., Doherty, J. U., Faillace, R., Maekawa, K., Arnold, S., Gavras, H. and Hood, Jr, W. B. (1982) Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows and plasma catecholamines. J. Clin. Invest. 69, 1321-1336
69. Stenvinkel, P., Bolinder, J. and Alvestrand, A. (1992) Effects of insulin on renal haemodynamics and the proximal and distal tubular sodium handling in healthy subjects. Diabetologia 35, 1042-1048
70. Stenvinkel, P., Ottosson-Seeberger, A. and Alvestrand, A. (1995) Renal hemodynamics and sodium handling in moderate renal insufficiency: the role of insulin resistance and dyslipidemia. J. Am. Soc. Nephrol. 5, 1751-1760
71. Herlitz, H., Widgren, B., Urbanavicius, V., Attvall, S. and Persson, B. (1996) Stimulatory effect of insulin on tubular sodium reabsorption in normotensive subjects with a positive family history of hypertension. Nephrol. Dial. Transplant. 11, 47-54
72. Ter Maaten, J. C., Bakker, S. J., Serne, E. H., Moshage, H. J., Donker, A. J. and Gans, R. O. (2000) Insulin-mediated increases in renal plasma flow are impaired in insulin-resistant normal subjects. Eur. J. Clin. Invest. 30, 1090-1098
73. DeFronzo, R. A., Cooke, C. R. andres, R., Faloona, G. R. and Davis, P. J. (1975) The effect of insulin on renal handling of sodium, potassium, calcium and phosphate in man. J. Clin. Invest. 55, 845-855
74. Vierhapper, H., Gasic, S., Roden, M. and Waldhausl, W. (1993) Increase in skeletal muscle blood flow but not in renal blood flow during euglycemic hyperinsulinemia in man. Horm. Metab. Res. 25, 438-441
75. Ward, K. D., Sparrow, D., Landsberg, L., Young, J. B., Vokonas, P. S. and Weiss, S. T. (1996) Influence of insulin, sympathetic nervous system activity and obesity on blood pressure: the Normative Aging Study. J. Hypertens. 14, 301-308
76. Cohen, A. J., McCarthy, D. M. and Stoff, J. S. (1989) Direct hemodynamic effect of insulin in the isolated perfused kidney. Am. J. Physiol. 257, F580-F585
77. Hayashi, K., Fujiwara, K., Oka, K., Nagahama, T., Matsuda, H. and Saruta, T. (1997) Effects of insulin on rat renal microvessels: studies in the isolated perfused hydronephrotic kidney. Kidney Int. 51, 1507-1513
78. Tucker, B. J., Mendonca, M. M. and Blantz, R. C. (1993) Contrasting effects of acute insulin infusion on renal function in awake nondiabetic and diabetic rats. J. Am. Soc. Nephrol. 3, 1686-1693
79. ter Maaten, J. C., Bakker, S. J., Serne, E. H., ter Wee, P. M., Donker, A. J. and Gans, R. O. (1999) Insulin's acute effects on glomerular filtration rate correlate with insulin sensitivity whereas insulin's acute effects on proximal tubular sodium reabsorption correlation with salt sensitivity in normal subjects. Nephrol. Dial. Transplant. 14, 2357-2363
80. Thameem, F., Puppala, S., Schneider, J., Bhandari, B., Arya, R., Arar, N. H., Vasylyeva, T. L., Farook, V. S., Fowler, S., Almasy, L. et al. (2012) The Gly972Arg variant of human insulin receptor substrate 1 gene is associated with variation in glomerular filtration rate likely through impaired insulin receptor signaling. Diabetes 61, 2385-2393
81. Simons, M. and Huber, T. B. (2008) It's not all about nephrin. Kidney Int. 73, 671-673
82. Saleem, M. A., Zavadil, J., Bailly, M., McGee, K., Witherden, I. R., Pavenstadt, H., Hsu, H., Sanday, J., Satchell, S. C., Lennon, R. et al. (2008) The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells. Am. J. Physiol. Renal Physiol. 295, F959-F970
83. Kobayashi, N., Gao, S. Y., Chen, J., Saito, K., Miyawaki, K., Li, C. Y., Pan, L., Saito, S., Terashita, T. and Matsuda, S. (2004) Process formation of the renal glomerular podocyte: is there common molecular machinery for processes of podocytes and neurons? Anat. Sci. Int. 79, 1-10
84. Sachs, N., Claessen, N., Aten, J., Kreft, M., Teske, G. J., Koeman, A., Zuurbier, C. J., Janssen, H. and Sonnenberg, A. (2012) Blood pressure influences end-stage renal disease of Cd151 knockout mice. J. Clin. Invest. 122, 348-358
85. Pozzi, A. and Zent, R. (2012) Hold tight or you'll fall off: CD151 helps podocytes stick in high-pressure situations. J. Clin. Invest. 122, 13-16
86. Kretzler, M. (2002) Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc. Res. Tech. 57, 247-253
87. Reddy, G. R., Kotlyarevska, K., Ransom, R. F. and Menon, R. K. (2008) The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy? Curr. Opin. Nephrol. Hypertens. 17, 32-36
88. Pavenstadt, H., Kriz, W. and Kretzler, M. (2003) Cell biology of the glomerular podocyte. Physiol. Rev. 83, 253-307
89. Welsh, G. I. and Saleem, M. A. (2011) The podocyte cytoskeleton-key to a functioning glomerulus in health and disease. Nat. Rev. Nephrol. 8, 14-21
90. Winn, M. P., Conlon, P. J., Lynn, K. L., Farrington, M. K., Creazzo, T., Hawkins, A. F., Daskalakis, N., Kwan, S. Y., Ebersviller, S., Burchette, J. L. et al. (2005) A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801-1804
91. Reiser, J., Polu, K. R., Moller, C. C., Kenlan, P., Altintas, M. M., Wei, C., Faul, C., Herbert, S., Villegas, I., Avila-Casado, C. et al. (2005) TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet. 37, 739-744
92. Heeringa, S. F., Chernin, G., Chaki, M., Zhou, W., Sloan, A. J., Ji, Z., Xie, L. X., Salviati, L., Hurd, T. W., Vega-Warner, V. et al. (2011) COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J. Clin. Invest. 121, 2013-2024
93. Hinkes, B., Wiggins, R. C., Gbadegesin, R., Vlangos, C. N., Seelow, D., Nurnberg, G., Garg, P., Verma, R., Chaib, H., Hoskins, B. E. et al. (2006) Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat. Genet. 38, 1397-1405
94. Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., Pons, D. A., Owen, R. J., Satchell, S. C., Miles, M. J. et al. (2010) Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 12, 329-340
95. Tejada, T., Catanuto, P., Ijaz, A., Santos, J. V., Xia, X., Sanchez, P., Sanabria, N., Lenz, O., Elliot, S. J. and Fornoni, A. (2008) Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death. Kidney Int. 73, 1385-1393
96. Saleem, M. A., O'Hare, M. J., Reiser, J., Coward, R. J., Inward, C. D., Farren, T., Xing, C. Y., Ni, L., Mathieson, P. W. and Mundel, P. (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 13, 630-638
97. Coward, R. J., Welsh, G. I., Yang, J., Tasman, C., Lennon, R., Koziell, A., Satchell, S., Holman, G. D., Kerjaschki, D., Tavare, J. M. et al. (2005) The human glomerular podocyte is a novel target for insulin action. Diabetes 54, 3095-3102
98. Coward, R. J., Welsh, G. I., Koziell, A., Hussain, S., Lennon, R., Ni, L., Tavare, J. M., Mathieson, P. W. and Saleem, M. A. (2007) Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 56, 1127-1135
99. Fornoni, A., Jeon, J., Varona Santos, J., Cobianchi, L., Jauregui, A., Inverardi, L., Mandic, S. A., Bark, C., Johnson, K., McNamara, G. et al. (2010) Nephrin is expressed on the surface of insulin vesicles and facilitates glucose-stimulated insulin release. Diabetes 59, 190-199
100. Kim, E. Y. anderson, M. and Dryer, S. E. (2011) Insulin increases surface expression of TRPC6 channels in podocytes: Role of NADPH oxidases and reactive oxygen species. Am. J. Physiol. Renal Physiol. 302, F298-F307
101. Kim, E. Y. and Dryer, S. E. (2011) Effects of insulin and high glucose on mobilization of slo1 BKCa channels in podocytes. J. Cell Physiol. 226, 2307-2315
102. Bar, R. S., Hoak, J. C. and Peacock, M. L. (1978) Insulin receptors in human endothelial cells: identification and characterization. J. Clin. Endocrinol. Metab. 47, 699-702
103. Conti, F. G., Elliot, S. J., Striker, L. J. and Striker, G. E. (1989) Binding of insulin-like growth factor-I by glomerular endothelial and epithelial cells: further evidence for IGF-I action in the renal glomerulus. Biochem. Biophys. Res. Commun. 163, 952-958
104. Nitert, M. D., Chisalita, S. I., Olsson, K., Bornfeldt, K. E. and Arnqvist, H. J. (2005) IGF-I/insulin hybrid receptors in human endothelial cells. Mol. Cell. Endocrinol. 229, 31-37
105. Rabkin, R., Tsao, T., Elliot, S. J., Striker, L. J. and Striker, G. E. (1993) Insulin uptake and processing by cultured mouse glomerular endothelial cells. Am. J. Physiol. 265, C453-C459
106. Satchell, S. C., Tasman, C. H., Singh, A., Ni, L., Geelen, J., von Ruhland, C. J., O'Hare, M, J., Saleem, M. A., van den Heuvel, L. P. and Mathieson, P. W. (2006) Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 69, 1633-1640
107. Mima, A., Ohshiro, Y., Kitada, M., Matsumoto, M., Geraldes, P., Li, C., Li, Q., White, G. S., Cahill, C., Rask-Madsen, C. et al. (2011) Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int. 79, 883-896
108. Kubota, T., Kubota, N., Kumagai, H., Yamaguchi, S., Kozono, H., Takahashi, T., Inoue, M., Itoh, S., Takamoto, I., Sasako, T. et al. (2011) Impaired insulin signaling in endothelial cells reduces insulin-induced glucose uptake by skeletal muscle. Cell Metab. 13, 294-307
109. Sauer, B. (1998) Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381-392
110. Patrakka, J., Xiao, Z., Nukui, M., Takemoto, M., He, L., Oddsson, A., Perisic, L., Kaukinen, A., Szigyarto, C. A., Uhlen, M. et al. (2007) Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2 and 2310066E14Rik. J. Am. Soc. Nephrol. 18, 689-697
111. Abrass, C. K. (1995) Diabetic nephropathy. Mechanisms of mesangial matrix expansion. West J. Med. 162, 318-321
112. Kreisberg, J. I. and Ayo, S. H. (1993) The glomerular mesangium in diabetes mellitus. Kidney Int. 43, 109-113
113. Okuda, T., Yamashita, N. and Kurokawa, K. (1986) Angiotensin II and vasopressin stimulate calcium-activated chloride conductance in rat mesangial cells. J. Clin. Invest. 78, 1443-1448
114. Wang, X., Pluznick, J. L., Settles, D. C. and Sansom, S. C. (2007) Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells. Am. J. Physiol. Renal Physiol. 293, F1768-F1776
115. Soos, M. A. and Siddle, K. (1989) Immunological relationships between receptors for insulin and insulin-like growth factor I: evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem. J. 263, 553-563
116. Dalla Vestra, M., Saller, A., Mauer, M. and Fioretto, P. (2001) Role of mesangial expansion in the pathogenesis of diabetic nephropathy. J. Nephrol. 14 (Suppl. 4), S51-S57
117. Foutz, R. M., Grimm, P. R. and Sansom, S. C. (2008) Insulin increases the activity of mesangial BK channels through MAPK signaling. Am. J. Physiol. Renal Physiol. 294, F1465-F1472
118. Heilig, C. W., Liu, Y., England, R. L., Freytag, S. O., Gilbert, J. D., Heilig, K. O., Zhu, M., Concepcion, L. A. and Brosius, III, F. C. (1997) D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy. Diabetes 46, 1030-1039
119. Heilig, C. W., Concepcion, L. A., Riser, B. L., Freytag, S. O., Zhu, M. and Cortes, P. (1995) Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J. Clin. Invest. 96, 1802-1814
120. Weigert, C., Brodbeck, K., Brosius, III, F. C., Huber, M., Lehmann, R., Friess, U., Facchin, S., Aulwurm, S., Haring, H. U., Schleicher, E. D. et al. (2003) Evidence for a novel TGF-β1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. Diabetes 52, 527-535
121. Alarcon, C., Morales, A. V., Pimentel, B., Serna, J. and de Pablo, F. (1998) (Pro)insulin and insulin-like growth factor I complementary expression and roles in early development. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121, 13-17
122. Masters, B. A., Werner, H., Roberts, Jr, C. T., LeRoith, D. and Raizada, M. K. (1991) Developmental regulation of insulin-like growth factor-I-stimulated glucose transporter in rat brain astrocytes. Endocrinology 128, 2548-2557
123. Hernandez, E. R., Hurwitz, A., Botero, L., Ricciarelli, E., Werner, H., Roberts, Jr, C. T., LeRoith, D. and Adashi, E. Y. (1991) Insulin-like growth factor receptor gene expression in the rat ovary: divergent regulation of distinct receptor species. Mol. Endocrinol. 5, 1799-1805
124. Werner, H., Stannard, B., Bach, M. A., Roberts, Jr, C. T. and LeRoith, D. (1991) Regulation of insulin-like growth factor I receptor gene expression in normal and pathological states. Adv. Exp. Med. Biol. 293, 263-272
125. Kurokawa, K. and Lerner, R. L. (1980) Binding and degradation of insulin by isolated renal cortical tubules. Endocrinology 106, 655-662
126. Pillion, D. J., Haskell, J. F. and Meezan, E. (1988) Distinct receptors for insulin-like growth factor I in rat renal glomeruli and tubules. Am. J. Physiol. 255, E504-E512
127. Meezan, E. and Freychet, P. (1980) Specific insulin receptors in rat renal glomeruli. Renal Physiol. 3, 72-78
128. Baum, M. (1987) Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J. Clin. Invest. 79, 1104-1109
129. 2+ transports in TAL of mouse nephron: cross-potentiation with AVP. Am. J. Physiol. 265, F361-F369
130. Ito, O., Kondo, Y., Takahashi, N., Kudo, K., Igarashi, Y., Omata, K., Imai, Y. and Abe, K. (1994) Insulin stimulates NaCl transport in isolated perfused MTAL of Henle's loop of rabbit kidney. Am. J. Physiol. 267, F265-F270
131. Takahashi, N., Ito, O. and Abe, K. (1996) Tubular effects of insulin. Hypertens. Res. 19 (Suppl. 1), S41-S45
132. + exchanger NHE3 by insulin. Am. J. Physiol. Renal Physiol. 292, F577-F585
133. + exchanger 3: biphasic response and glucocorticoid dependence. Am. J. Physiol. Renal Physiol. 283, F532-F539
134. Sohara, E., Rai, T., Yang, S. S., Ohta, A., Naito, S., Chiga, M., Nomura, N., Lin, S. H., Vandewalle, A., Ohta, E. et al. (2011) Acute insulin stimulation induces phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells and mouse kidney. PLoS ONE 6, e24277
135. Wang, J., Barbry, P., Maiyar, A. C., Rozansky, D. J., Bhargava, A., Leong, M., Firestone, G. L. and Pearce, D. (2001) SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport. Am. J. Physiol. Renal Physiol. 280, F303-F313
136. Zhang, Y. H., Alvarez de la Rosa, D., Canessa, C. M. and Hayslett, J. P. (2005) Insulin-induced phosphorylation of ENaC correlates with increased sodium channel function in A6 cells. Am. J. Physiol. Cell Physiol. 288, C141-C147
137. + /phosphate cotransporter. J. Bioenerg. Biomembr. 30, 187-194
138. 2+ uptake in mouse distal convoluted tubule cells. Am. J. Physiol. 277, F907-F913
139. Tiwari, S., Riazi, S. and Ecelbarger, C. A. (2007) Insulin's impact on renal sodium transport and blood pressure in health, obesity and diabetes. Am. J. Physiol. Renal Physiol. 293, F974-F984
140. Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053
141. Ford, E. S., Giles, W. H. and Dietz, W. H. (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, J. Am. Med. Assoc. 287, 356-359
142. Burrows, N. R., Wang, J., Geiss, L. S., Venkat Narayan, K. M. and Engelgau, M. M. (2005) Incidence of end-stage renal disease among persons with diabetes: United States, 1990-2002. MMWR 54, 1097-1100
143. World Health Organization (1999) Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva
144. Schrijvers, B. F., De Vriese, A. S. and Flyvbjerg, A. (2004) From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr. Rev. 25, 971-1010
145. Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L. and Meyer, T. W. (1997) Podocyte loss and progressive glomerular injury in type II diabetes. J. Clin. Invest. 99, 342-348
146. Haraldsson, B. and Jeansson, M. (2009) Glomerular filtration barrier. Curr. Opin. Nephrol. Hypertens. 18, 331-335
147. Yki-Jarvinen, H. and Koivisto, V. A. (1986) Natural course of insulin resistance in type I diabetes. N. Engl. J. Med. 315, 224-230
148. Andersen, A. R., Christiansen, J. S. andersen, J. K., Kreiner, S. and Deckert, T. (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25, 496-501
149. Orchard, T. J., Chang, Y. F., Ferrell, R. E., Petro, N. and Ellis, D. E. (2002) Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int. 62, 963-970
150. Hadjadj, S., Pean, F., Gallois, Y., Passa, P., Aubert, R., Weekers, L., Rigalleau, V., Bauduceau, B., Bekherraz, A., Roussel, R. et al. (2004) Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care 27, 2661-2668
151. Kuboki, K., Jiang, Z. Y., Takahara, N., Ha, S. W., Igarashi, M., Yamauchi, T., Feener, E. P., Herbert, T. P., Rhodes, C. J. and King, G. L. (2000) Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101, 676-681
152. Naruse, K., Rask-Madsen, C., Takahara, N., Ha, S. W., Suzuma, K., Way, K. J., Jacobs, J. R., Clermont, A. C., Ueki, K., Ohshiro, Y. et al. (2006) Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes 55, 691-698
153. Wolf, G., Chen, S. and Ziyadeh, F. N. (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54, 1626-1634
154. Wang, Y., Heilig, K., Saunders, T., Minto, A., Deb, D. K., Chang, A., Brosius, F., Monteiro, C. and Heilig, C. W. (2010) Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis. Am. J. Physiol. Renal Physiol. 299, F99-F111
155. Zhang, H., Schin, M., Saha, J., Burke, K., Holzman, L. B., Filipiak, W., Saunders, T., Xiang, M., Heilig, C. W. and Brosius, III, F. C. (2010) Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice. Am. J. Physiol. Renal Physiol. 299, F91-F98
156. Jim, B., Ghanta, M., Qipo, A., Fan, Y., Chuang, P. Y., Cohen, H. W., Abadi, M., Thomas, D. B. and He, J. C. (2012) Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS ONE 7, e36041
157. Patari, A., Forsblom, C., Havana, M., Taipale, H., Groop, P. H. and Holthofer, H. (2003) Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 52, 2969-2974
158. Doublier, S., Salvidio, G., Lupia, E., Ruotsalainen, V., Verzola, D., Deferrari, G. and Camussi, G. (2003) Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 52, 1023-1030
159. Garvey, W. T., Olefsky, J. M. and Marshall, S. (1986) Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes 35, 258-267
160. Venkatesan, N. and Davidson, M. B. (1995) Insulin resistance in rats harboring growth hormone-secreting tumors: decreased receptor number but increased kinase activity in liver. Metab., Clin. Exp. 44, 75-84
161. Clerk, L. H., Vincent, M. A., Barrett, E. J., Lankford, M. F. and Lindner, J. R. (2007) Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. Am. J. Physiol. Endocrinol. Metab. 293, E1804-E1809
162. Catena, C., Cavarape, A., Novello, M., Giacchetti, G. and Sechi, L. A. (2003) Insulin receptors and renal sodium handling in hypertensive fructose-fed rats. Kidney Int. 64, 2163-2171
163. Catena, C., Giacchetti, G., Novello, M., Colussi, G., Cavarape, A. and Sechi, L. A. (2003) Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Am. J. Hypertens. 16, 973-978
164. Mogensen, C. E., Christensen, N. J. and Gundersen, H. J. (1980) The acute effect of insulin on heart rate, blood pressure, plasma noradrenaline and urinary albumin excretion. The role of changes in blood glucose. Diabetologia 18, 453-457
165. Hegedus, L., Christensen, N. J., Mogensen, C. E. and Gundersen, H. J. (1980) Oral glucose increases urinary albumin excretion in normal subjects but not in insulin-dependent diabetics. Scand. J. Clin. Lab. Invest. 40, 479-482
166. Corman, B., Chami-Khazraji, S., Schaeverbeke, J. and Michel, J. B. (1988) Effect of feeding on glomerular filtration rate and proteinuria in conscious aging rats. Am. J. Physiol. 255, F250-F256
167. Uemasu, J., Hori, T., Uemasu, Y. and Kawasaki, H. (1991) Effects of a rice meal on renal hemodynamics and excretory functions in normal subjects. Nephron 57, 187-191
168. Isshiki, K., Haneda, M., Koya, D., Maeda, S., Sugimoto, T. and Kikkawa, R. (2000) Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes 49, 1022-1032
169. Panchapakesan, U., Chen, X. M. and Pollock, C. A. (2005) Drug insight: thiazolidinediones and diabetic nephropathy-relevance to renoprotection. Nat. Clin. Pract. Nephrol. 1, 33-43
170. Sarafidis, P. A., Stafylas, P. C., Georgianos, P. I., Saratzis, A. N. and Lasaridis, A. N. (2010) Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis. Am. J. Kidney Dis. 55, 835-847
171. Ma, L. J., Marcantoni, C., Linton, M. F., Fazio, S. and Fogo, A. B. (2001) Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int. 59, 1899-1910
172. Yang, H. C., Deleuze, S., Zuo, Y., Potthoff, S. A., Ma, L. J. and Fogo, A. B. (2009) The PPARγ agonist pioglitazone ameliorates aging-related progressive renal injury. J. Am. Soc. Nephrol. 20, 2380-2388
173. Lennon, R., Welsh, G. I., Singh, A., Satchell, S. C., Coward, R. J., Tavare, J. M., Mathieson, P. W. and Saleem, M. A. (2009) Rosiglitazone enhances glucose uptake in glomerular podocytes using the glucose transporter GLUT1. Diabetologia 52, 1944-1952
174. Lennon, R., Pons, D., Sabin, M. A., Wei, C., Shield, J. P., Coward, R. J., Tavare, J. M., Mathieson, P. W., Saleem, M. A. and Welsh, G. I. (2009) Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. Nephrol. Dial. Transplant. 24, 3288-3296
175. Hyvonen, M. E., Saurus, P., Wasik, A., Heikkila, E., Havana, M., Trokovic, R., Saleem, M., Holthofer, H. and Lehtonen, S. (2010) Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes. Mol. Cell. Endocrinol. 328, 70-79
176. Lee, M. P. and Sweeney, G. (2006) Insulin increases gelatinase activity in rat glomerular mesangial cells via ERK- and PI-3 kinase-dependent signalling. Diabetes Obes. Metab 8, 281-288
177. Isshiki, K., He, Z., Maeno, Y., Ma, R. C., Yasuda, Y., Kuroki, T., White, G. S., Patti, M. E., Weir, G. C. and King, G. L. (2008) Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cells. Kidney Int. 74, 1434-1443
178. Ling, B. N., Seal, E. E. and Eaton, D. C. (1993) Regulation of mesangial cell ion channels by insulin and angiotensin II. Possible role in diabetic glomerular hyperfiltration. J. Clin. Invest. 92, 2141-2151
179. Wullschleger, S., Loewith, R. and Hall, M. N. (2006) TOR signaling in growth and metabolism. Cell 124, 471-484
180. Hay, N. and Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945
181. Huber, T. B., Walz, G. and Kuehn, E. W. (2011) mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression. Kidney Int. 79, 502-511
182. Takano, A., Usui, I., Haruta, T., Kawahara, J., Uno, T., Iwata, M. and Kobayashi, M. (2001) Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol. Cell. Biol. 21, 5050-5062
183. Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S. et al. (2012) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 335, 1638-1643
184. Lieberthal, W. and Levine, J. S. (2009) The role of the mammalian target of rapamycin (mTOR) in renal disease. J. Am. Soc. Nephrol. 20, 2493-2502
185. Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Ruegg, M. A., Hall, M. N. et al. (2011) mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J. Clin. Invest. 121, 2181-2196
186. Godel, M., Hartleben, B., Herbach, N., Liu, S., Zschiedrich, S., Lu, S., Debreczeni-Mor, A., Lindenmeyer, M. T., Rastaldi, M. P., Hartleben, G. et al. (2011) Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J. Clin. Invest. 121, 2197-2209
187. Cina, D. P., Onay, T., Paltoo, A., Li, C., Maezawa, Y., De Arteaga, J., Jurisicova, A. and Quaggin, S. E. (2011) Inhibition of MTOR disrupts autophagic flux in podocytes. J. Am. Soc. Nephrol. 23, 412-420
188. Lloberas, N., Cruzado, J. M., Franquesa, M., Herrero-Fresneda, I., Torras, J., Alperovich, G., Rama, I., Vidal, A. and Grinyo, J. M. (2006) Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J. Am. Soc. Nephrol. 17, 1395-1404
189. Yang, Y., Wang, J., Qin, L., Shou, Z., Zhao, J., Wang, H., Chen, Y. and Chen, J. (2007) Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am. J. Nephrol. 27, 495-502
190. Mori, H., Inoki, K., Masutani, K., Wakabayashi, Y., Komai, K., Nakagawa, R., Guan, K. L. and Yoshimura, A. (2009) The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem. Biophys. Res. Commun. 384, 471-475
191. Torras, J., Herrero-Fresneda, I., Gulias, O., Flaquer, M., Vidal, A., Cruzado, J. M., Lloberas, N., Franquesa, M. and Grinyo, J. M. (2009) Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? Nephrol. Dial. Transplant. 24, 3632-3640
192. Amer, H. and Cosio, F. G. (2009) Significance and management of proteinuria in kidney transplant recipients. J. Am. Soc. Nephrol. 20, 2490-2492
193. Letavernier, E. and Legendre, C. (2008) mToR inhibitors-induced proteinuria: mechanisms, significance and management. Transplant. Rev. 22, 125-130
194. Letavernier, E., Bruneval, P., Mandet, C., Duong Van Huyen, J. P., Peraldi, M. N., Helal, I., Noel, L. H. and Legendre, C. (2007) High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin. J. Am. Soc. Nephrol. 2, 326-333
195. Tiwari, S., Sharma, N., Gill, P. S., Igarashi, P., Kahn, C. R., Wade, J. B. and Ecelbarger, C. M. (2008) Impaired sodium excretion and increased blood pressure in mice with targeted deletion of renal epithelial insulin receptor. Proc. Natl. Acad. Sci. U.S.A. 105, 6469-6474
196. Shen, S. S., Krishna, B., Chirala, R., Amato, R. J. and Truong, L. D. (2005) Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod. Pathol. 18, 933-940
197. Musso, C., Javor, E., Cochran, E., Balow, J. E. and Gorden, P. (2006) Spectrum of renal diseases associated with extreme forms of insulin resistance. Clin. J. Am. Soc. Nephrol. 1, 616-622
198. Arioglu, E., andewelt, A., Diabo, C., Bell, M., Taylor, S. I. and Gorden, P. (2002) Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective. Medicine 81, 87-100
199. Tsokos, G. C., Gorden, P., Antonovych, T., Wilson, C. B. and Balow, J. E. (1985) Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors. Ann. Intern. Med. 102, 176-181
200. Musso, C., Cochran, E., Moran, S. A., Skarulis, M. C., Oral, E. A., Taylor, S. and Gorden, P. (2004) Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective. Medicine 83, 209-222
201. Woodcock, J., Sharfstein, J. M. and Hamburg, M. (2010) Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. N. Engl. J. Med. 363, 1489-1491
202. Kestila, M., Lenkkeri, U., Mannikko, M., Lamerdin, J., McCready, P., Putaala, H., Ruotsalainen, V., Morita, T., Nissinen, M., Herva, R. et al. (1998) Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol. Cell 1, 575-582
203. Donoviel, D. B., Freed, D. D., Vogel, H., Potter, D. G., Hawkins, E., Barrish, J. P., Mathur, B. N., Turner, C. A., Geske, R., Montgomery, C. A. et al. (2001) Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol. Cell. Biol. 21, 4829-4836
204. Kaplan, J. M., Kim, S. H., North, K. N., Rennke, H., Correia, L. A., Tong, H. Q., Mathis, B. J., Rodriguez-Perez, J. C., Allen, P. G., Beggs, A. H. et al. (2000) Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24, 251-256
205. Yang, Y., Jeanpierre, C., Dressler, G. R., Lacoste, M., Niaudet, P. and Gubler, M. C. (1999) WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am. J. Pathol. 154, 181-192
206. Dreyer, S. D., Zhou, G., Baldini, A., Winterpacht, A., Zabel, B., Cole, W., Johnson, R. L. and Lee, B. (1998) Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat. Genet. 19, 47-50
207. Kim, J. M., Wu, H., Green, G., Winkler, C. A., Kopp, J. B., Miner, J. H., Unanue, E. R. and Shaw, A. S. (2003) CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300, 1298-1300
208. Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M. C., Niaudet, P. and Antignac, C. (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24, 349-354
209. Brown, E. J., Schlondorff, J. S., Becker, D. J., Tsukaguchi, H., Uscinski, A. L., Higgs, H. N., Henderson, J. M. and Pollak, M. R. (2009) Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat. Genet. 42, 72-76
210. Inoue, T., Yaoita, E., Kurihara, H., Shimizu, F., Sakai, T., Kobayashi, T., Ohshiro, K., Kawachi, H., Okada, H., Suzuki, H. et al. (2001) FAT is a component of glomerular slit diaphragms. Kidney Int. 59, 1003-1012